The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2023
Filed:
May. 10, 2023
Applicant:
Inipharm, Inc., Bellevue, WA (US);
Inventors:
Sampath Kumar Anandan, Fremont, CA (US);
Joshua Odingo, Bothell, WA (US);
Heather Kay Webb Hsu, Seattle, WA (US);
Vincent Florio, Seattle, WA (US);
Subramanyam Janardhan Tantry, Bangalore, IN;
Athisayamani Jeyaraj Duraiswamy, Bangalore, IN;
Assignee:
INIPHARM, INC., Bellevue, WA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/06 (2006.01); C07D 239/91 (2006.01); C07D 417/06 (2006.01); C07D 413/06 (2006.01); C07D 403/06 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 401/14 (2006.01);
U.S. Cl.
CPC ...
C07D 401/06 (2013.01); C07D 239/91 (2013.01); C07D 401/10 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 403/10 (2013.01); C07D 413/06 (2013.01); C07D 417/06 (2013.01); C07B 2200/05 (2013.01);
Abstract
Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).